Rich Welsh

just a man trying to do his best to make it

[Rich Welsh @rwelsh63]

NervGen NVG-291 Update: 10/10 Spinal Cord Injury Patients Responded! #s... https://t.co/3WpoFwklb8 via @YouTube @US_FDA What are you waiting for?

[The Daily Norseman @DailyNorseman]

The 1998 NFC Championship Game

[Rich Welsh @rwelsh63]

🚨 Phase 3 RESTORE trial for NervGen’s NVG-291 just hit another milestone!
Shepherd Center has posted the study — first major U.S. site is now in start-up for chronic tetraplegia (cervical SCI).
Recruitment is “Coming Soon” (targeted mid-2026), but you can already submit the interest form to be notified when screening opens:
👉 https://t.co/yOJtaj3r5B
Huge step toward restoring hand function and independence after SCI.
Follow @NervGen for updates and check https://t.co/Oi5Uz8G2Bj.
#SCI #SpinalCordInjury #NVG291 #NervGen #NeuroRepair #RESTOREtrial $NGEN

[Rich Welsh @rwelsh63]

I’m not the only one!

[Rich Welsh @rwelsh63]

🚨 After 20+ years of dead ends, we’re FINALLY this close to the first-ever drug for spinal cord injury.
NervGen’s NVG-291 just cleared its End-of-Phase 2 FDA meeting. Phase 3 (RESTORE) launches mid-2026.
No approved repair therapy exists today — not stem cells, not anything. But NVG-291 data showed real, lasting gains in hand function, mobility, bladder control, and independence that kept improving after treatment stopped! 
It’s just a peptide. Fast Track + Orphan Drug status.
Timeline: Phase 3 data ~2028 → possible approval in under 3 years.
Next targets: stroke, MS, hearing loss.
Why the silence? Small biotech, not flashy headlines. But this is the closest we’ve ever been.
SCI community — this one’s for you. Spread it. $NGEN #NervGen #NVG291 #SpinalCordInjury #NeuroRepair

[Brigham Buhler @ferrisbuhler81]

Peptides signal your body to optimize, heal, and recover, working with what’s already natural. Drugs are designed to force a specific response.

[Rich Welsh @rwelsh63]

@US_FDA @DrMakaryFDA NVG-291 for spinal cord injuries!! Approve it please!!

[Rich Welsh @rwelsh63]

@DrSamuelBHume $NGEN NervGen Pharma would be very wise investment

[Rich Welsh @rwelsh63]

@DrMakaryFDA $NGEN NervGen Pharma first EVER treatment for Spinal Cord Injury, proven results for a Unmet Need that can allow patients to walk again!!!!

[Rich Welsh @rwelsh63]

@Gantosj welcome to party!

[Rich Welsh @rwelsh63]

🚨 With RFK Jr., Dr. Marty Makary & the FDA talking peptides nonstop right now… Here’s one that could actually change lives FOREVER!
NervGen Pharma’s NVG-291 — a first-in-class neuroreparative peptide — just delivered something never seen before in clinical trials:
For the first time ever, it showed neurons reconnecting and the nervous system repairing itself after chronic spinal cord injury.
In the CONNECT SCI Phase 1b/2a trial (chronic patients, up to 10 years post-injury):
• Dramatic, durable gains in hand function, independence & quality of life (even weeks after treatment stopped)
• 75% of treated patients reported being “much” or “very much” improved vs. 33% on placebo
• Improved bladder control, reduced spasticity, and real-world daily function most patients thought was impossible
And it’s not stopping at SCI.
Preclinical studies have already shown strong positive results in stroke, traumatic brain injury, MS, ALS, and even blast-induced hearing loss.
The FDA just greenlit the Phase 3 RESTORE trial for chronic tetraplegia. Fast Track + Orphan Drug status secured.
This is what “Make America Healthy Again” looks like in action — actual nervous system repair, not just symptom management.
NervGen is leading the future of neurorepair.
Follow the science → https://t.co/Oi5Uz8G2Bj
#Peptides #NeuroRepair #SpinalCordInjury #RFKJr #MAHA #NVG291 #NervGen @joerogan @DrMakaryFDA @FDA_Drug_Info @RobertKennedyJr @realDonaldTrump @NervgenP @ruffoloj

[Rich Welsh @rwelsh63]

@HHSResponse @US_FDA @SecKennedy Can you please approve NVG – 291. People that have been paralyzed have waited long enough! NervGen Pharma is starting a phase 3, where it proven positive results, but FDA is just dragging it along!

[Rich Welsh @rwelsh63]

@DrMakaryFDA Thats great, Now let NervGen Pharma put NVG-291 to the people that need it, MS, ALS, Stroke & Hearing loss!

[Rich Welsh @rwelsh63]

@FoxNews @US_FDA @realDonaldTrump @DrMakaryFDA many letters and emails to FDA obviously isn’t working, Trump get FDA approval of NVG-291! Let people in wheelchairs walk again!

[Rich Welsh @rwelsh63]

Here’s a few great pics of my boys last race @NorthlandMX

[Rich Welsh @rwelsh63]

@elonmusk Right now NVG-291 from NervGen Pharma is the closest to enable quadriplegics to walk and use ther hands! Its worth the google!

[Rich Welsh @rwelsh63]

825% Hand Improvement? NervGen NVG-291 SCI Final Results Are In. Plus P... https://t.co/vC3HqIlQ3I via @YouTube @US_FDA @DrMakaryFDA #AcceleradedApproval #SCI

[Rich Welsh @rwelsh63]

After 25+ years paralyzed from a car accident, I’ve seen the “mice walking” headlines for decades. This is different — REAL results in PEOPLE. NVG-291 from NervGen Pharma (developed at Case Western Reserve incubator) is helping spinal cord injury patients open their hands, walk short distances, regain arm/leg function & independence. Phase 2 success is here! Article: https://t.co/8S3d5ZV5Qz FDA — approve this ASAP. We’ve waited long enough! #CureParalysis #SCI #NVG291 @US_FDA @DrMakaryFDA

[Rich Welsh @rwelsh63]

@m_goes_distance @grok explain to them the breakthrough of $NGEN NVG-291 and how it’s going to change so many lives!

[Rich Welsh @rwelsh63]

@siemionowkris @WhiteHouse @US_FDA NervGen Pharma can get NVG-291 trials started on MS, Stroke, ALS, @ hearing loss! NVG-291 is a miracle drug